Two Firsts For US Hand Sanitizer Firm: False COVID-19 Claims, Revamped Monograph Violation

Less than a month after Congress passed legislation to comprehensively overhaul the FDA's OTC monograph program, the agency's warning to Prefense explains that its product formulation is noncompliant under amendments to the program.